Kure Cells Inc. is developing investigational cell therapies, including UF-Kure19 which are currently being evaluated in clinical trials.
At this time, Kure Cells does not offer expanded access (also known as compassionate use) to its investigational products outside of clinical studies. This decision reflects the early stage of development, the need to collect safety and efficacy data in controlled settings, and the limited manufacturing capacity for investigational material.
We understand the interest in potential access to investigational therapies and will continue to evaluate our policy as additional data becomes available and development progresses.
Patients and physicians seeking information about ongoing clinical trials may visit ClinicalTrials.gov and search for “UF-KURE19” or contact us at inquiries@kure.ai for trial information.
Last updated [Oct 2025].